Regal Investment Advisors LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1559789 KENTWOOD, MI

Position in ALNY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$732,104

-$158,267 QoQ

Shares Held

2,432

-9.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#438

of 784 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 1% None 99%

Healthcare · as of Jun 30, 2026

Regal Investment Advisors LLC holds $10,476,569 across 7 Biotechnology names. ALNY ranks #4 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	103,861	$5,823,486
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,238	$1,608,411
3	KRYS	Krystal Biotech, Inc.	3,913	$1,454,344
4	ALNY	Alnylam Pharmaceuticals, Inc. This page	2,432	$732,104
5	BMRN	Biomarin Pharmaceutical Inc	9,366	$535,922
6	DFTX	Definium Therapeutics, Inc.	5,709	$268,551
7	VSTM	Verastem, Inc.	14,071	$53,751

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$732,104	2,432	-9.6%	Shares	Sole	2026-08-14
2026-03-31	$890,371	2,691	-0.8%	Shares	Sole	2026-05-14
2025-12-31	$1,079,222	2,714	+0.4%	Shares	Sole	2026-02-17
2025-09-30	$1,232,112	2,702	-7.0%	Shares	Sole	2025-11-13
2025-06-30	$947,617	2,906	0.0%	Shares	Sole	2025-08-11
2025-03-31	$784,678	2,906	-8.0%	Shares	Sole	2025-05-12
2024-12-31	$743,108	3,158	-0.6%	Shares	Sole	2025-02-13
2024-09-30	$873,770	3,177	-5.1%	Shares	Sole	2024-11-12
2024-06-30	$813,564	3,348	+4.1%	Shares	Sole	2024-08-15
2024-03-31	$480,631	3,216	+8.5%	Shares	Sole	2024-05-15
2023-12-31	$567,530	2,965	+5.8%	Shares	Sole	2024-02-14
2023-09-30	$496,411	2,803	+0.3%	Shares	Sole	2023-11-13
2023-06-30	$530,882	2,795	+43.9%	Shares	Sole	2023-08-11
2023-03-31	$389,021	1,942	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.